- Home
- SERA vs DMA Comparison
SERA vs DMA Comparison
Compare SERA & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- DMA
- Stock Information
- Founded
- SERA 2008
- DMA 2011
- Country
- SERA United States
- DMA United States
- Employees
- SERA N/A
- DMA N/A
- Industry
- SERA Precision Instruments
- DMA Trusts Except Educational Religious and Charitable
- Sector
- SERA Health Care
- DMA Finance
- Exchange
- SERA Nasdaq
- DMA Nasdaq
- Market Cap
- SERA 90.6M
- DMA 78.8M
- IPO Year
- SERA 2021
- DMA N/A
- Fundamental
- Price
- SERA $3.25
- DMA $8.76
- Analyst Decision
- SERA
- DMA
- Analyst Count
- SERA 0
- DMA 0
- Target Price
- SERA N/A
- DMA N/A
- AVG Volume (30 Days)
- SERA 44.5K
- DMA 34.6K
- Earning Date
- SERA 11-05-2025
- DMA 01-01-0001
- Dividend Yield
- SERA N/A
- DMA 2.04%
- EPS Growth
- SERA N/A
- DMA N/A
- EPS
- SERA N/A
- DMA N/A
- Revenue
- SERA $108,000.00
- DMA N/A
- Revenue This Year
- SERA $217.92
- DMA N/A
- Revenue Next Year
- SERA $479.25
- DMA N/A
- P/E Ratio
- SERA N/A
- DMA N/A
- Revenue Growth
- SERA 0.94
- DMA N/A
- 52 Week Low
- SERA $1.37
- DMA $4.78
- 52 Week High
- SERA $9.13
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- SERA 57.38
- DMA 57.49
- Support Level
- SERA $3.11
- DMA $8.68
- Resistance Level
- SERA $3.40
- DMA $8.85
- Average True Range (ATR)
- SERA 0.18
- DMA 0.11
- MACD
- SERA 0.00
- DMA 0.01
- Stochastic Oscillator
- SERA 81.09
- DMA 74.15
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.